These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25596865)

  • 41. Metabotropic glutamate receptor 5 neuroimaging in schizophrenia.
    Akkus F; Treyer V; Ametamey SM; Johayem A; Buck A; Hasler G
    Schizophr Res; 2017 May; 183():95-101. PubMed ID: 27847228
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of a bolus/infusion protocol for 11C-ABP688, a PET tracer for mGluR5.
    Burger C; Deschwanden A; Ametamey S; Johayem A; Mancosu B; Wyss M; Hasler G; Buck A
    Nucl Med Biol; 2010 Oct; 37(7):845-51. PubMed ID: 20870160
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radiolabeling and in vitro and in vivo evaluation of [18F]-FE-DABP688 as a PET radioligand for the metabotropic glutamate receptor subtype 5.
    Honer M; Stoffel A; Kessler LJ; Schubiger PA; Ametamey SM
    Nucl Med Biol; 2007 Nov; 34(8):973-80. PubMed ID: 17998101
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A first-in-man PET study of [
    Warnock G; Sommerauer M; Mu L; Pla Gonzalez G; Geistlich S; Treyer V; Schibli R; Buck A; Krämer SD; Ametamey SM
    Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):1041-1051. PubMed ID: 29177707
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A positron emission tomography study in healthy volunteers to estimate mGluR5 receptor occupancy of AZD2066 - estimating occupancy in the absence of a reference region.
    Kågedal M; Cselényi Z; Nyberg S; Raboisson P; Ståhle L; Stenkrona P; Varnäs K; Halldin C; Hooker AC; Karlsson MO
    Neuroimage; 2013 Nov; 82():160-9. PubMed ID: 23668965
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Marked global reduction in mGluR5 receptor binding in smokers and ex-smokers determined by [11C]ABP688 positron emission tomography.
    Akkus F; Ametamey SM; Treyer V; Burger C; Johayem A; Umbricht D; Gomez Mancilla B; Sovago J; Buck A; Hasler G
    Proc Natl Acad Sci U S A; 2013 Jan; 110(2):737-42. PubMed ID: 23248277
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The metabotropic glutamate receptor 5 radioligand [
    Varnäs K; Juréus A; Finnema SJ; Johnström P; Raboisson P; Amini N; Takano A; Stepanov V; Halldin C; Farde L
    Neuropharmacology; 2018 Jun; 135():455-463. PubMed ID: 29608920
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathophysiology of the behavioral variant of frontotemporal lobar degeneration: A study combining MRI and FDG-PET.
    Buhour MS; Doidy F; Laisney M; Pitel AL; de La Sayette V; Viader F; Eustache F; Desgranges B
    Brain Imaging Behav; 2017 Feb; 11(1):240-252. PubMed ID: 26852326
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PET imaging of mGluR5 in Alzheimer's disease.
    Mecca AP; McDonald JW; Michalak HR; Godek TA; Harris JE; Pugh EA; Kemp EC; Chen MK; Salardini A; Nabulsi NB; Lim K; Huang Y; Carson RE; Strittmatter SM; van Dyck CH
    Alzheimers Res Ther; 2020 Jan; 12(1):15. PubMed ID: 31954399
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabotropic glutamate receptor 5 binding in patients with obsessive-compulsive disorder.
    Akkus F; Terbeck S; Ametamey SM; Rufer M; Treyer V; Burger C; Johayem A; Mancilla BG; Sovago J; Buck A; Hasler G
    Int J Neuropsychopharmacol; 2014 Dec; 17(12):1915-22. PubMed ID: 24833114
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [
    Esterlis I; DellaGioia N; Pietrzak RH; Matuskey D; Nabulsi N; Abdallah CG; Yang J; Pittenger C; Sanacora G; Krystal JH; Parsey RV; Carson RE; DeLorenzo C
    Mol Psychiatry; 2018 Apr; 23(4):824-832. PubMed ID: 28397841
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predominant subcortical accumulation of
    Cho H; Seo SW; Choi JY; Lee HS; Ryu YH; Lee MS; Na DL; Kim HJ; Lyoo CH
    Neurobiol Aging; 2018 Jun; 66():112-121. PubMed ID: 29554554
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Longitudinal structural and metabolic changes in frontotemporal dementia.
    Bejanin A; Tammewar G; Marx G; Cobigo Y; Iaccarino L; Kornak J; Staffaroni AM; Dickerson BC; Boeve BF; Knopman DS; Gorno-Tempini M; Miller BL; Jagust WJ; Boxer AL; Rosen HJ; Rabinovici GD
    Neurology; 2020 Jul; 95(2):e140-e154. PubMed ID: 32591470
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro and in vivo evaluation of [18F]-FDEGPECO as a PET tracer for imaging the metabotropic glutamate receptor subtype 5 (mGluR5).
    Wanger-Baumann CA; Mu L; Honer M; Belli S; Alf MF; Schubiger PA; Krämer SD; Ametamey SM
    Neuroimage; 2011 Jun; 56(3):984-91. PubMed ID: 21406237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of the metabotropic glutamate receptor subtype 5 using PET and 11C-ABP688: assessment of methods.
    Treyer V; Streffer J; Wyss MT; Bettio A; Ametamey SM; Fischer U; Schmidt M; Gasparini F; Hock C; Buck A
    J Nucl Med; 2007 Jul; 48(7):1207-15. PubMed ID: 17574984
    [TBL] [Abstract][Full Text] [Related]  

  • 56. mGluR5 binding changes during a mismatch negativity task in a multimodal protocol with [
    Régio Brambilla C; Veselinović T; Rajkumar R; Mauler J; Matusch A; Ruch A; Orth L; Ramkiran S; Sbaihat H; Kaulen N; Khudeish NY; Wyss C; Heekeren K; Kawohl W; Rota Kops E; Tellmann L; Scheins J; Boers F; Neumaier B; Ermert J; Lang M; Stüsgen S; Herzog H; Langen KJ; Shah NJ; Lerche CW; Neuner I
    Transl Psychiatry; 2022 Jan; 12(1):6. PubMed ID: 35013095
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional Analysis of Brain Imaging Suggests Changes in the Availability of mGluR5 and Altered Connectivity in the Cerebral Cortex of Long-Term Abstaining Males with Alcohol Dependence: A Preliminary Study.
    Joo YH; Kim JH; Kim HK; Son YD; Cumming P; Kim JH
    Life (Basel); 2021 May; 11(6):. PubMed ID: 34070900
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients.
    Jeong Y; Cho SS; Park JM; Kang SJ; Lee JS; Kang E; Na DL; Kim SE
    J Nucl Med; 2005 Feb; 46(2):233-9. PubMed ID: 15695781
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative positron emission tomography of mGluR5 in rat brain with [(18) F]PSS232 at minimal invasiveness and reduced model complexity.
    Müller Herde A; Keller C; Milicevic Sephton S; Mu L; Schibli R; Ametamey SM; Krämer SD
    J Neurochem; 2015 May; 133(3):330-42. PubMed ID: 25439096
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduced uptake of [11C]-ABP688, a PET tracer for metabolic glutamate receptor 5 in hippocampus and amygdala in Alzheimer's dementia.
    Treyer V; Gietl AF; Suliman H; Gruber E; Meyer R; Buchmann A; Johayem A; Unschuld PG; Nitsch RM; Buck A; Ametamey SM; Hock C
    Brain Behav; 2020 Jun; 10(6):e01632. PubMed ID: 32304284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.